The latest closing stock price for Protara Therapeutics as of September 18, 2024 is 1.92.
An investor who bought $1,000 worth of Protara Therapeutics stock at the IPO in 2014 would have $-995 today, roughly -1 times their original investment - a -41.39% compound annual growth rate over 10 years.
The all-time high Protara Therapeutics stock closing price was 800.00 on July 17, 2015.
The Protara Therapeutics 52-week high stock price is 5.24, which is 172.9% above the current share price.
The Protara Therapeutics 52-week low stock price is 1.04, which is 45.8% below the current share price.
The average Protara Therapeutics stock price for the last 52 weeks is 2.41.
An investor who bought $1,000 worth of Protara Therapeutics stock at the IPO in 2014 would have $-995 today, roughly -1 times their original investment - a -41.39% compound annual growth rate over 10 years.
The all-time high Protara Therapeutics stock closing price was 800.00 on July 17, 2015.
The Protara Therapeutics 52-week high stock price is 5.24, which is 172.9% above the current share price.
The Protara Therapeutics 52-week low stock price is 1.04, which is 45.8% below the current share price.
The average Protara Therapeutics stock price for the last 52 weeks is 2.41.